Clinical Trial Update: A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating an exercise program in patients with metastatic castration-resistant prostate cancer undergoing docetaxel-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Prostatic Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED